This topic contains a solution. Click here to go to the answer

Author Question: Injecting an animal with a dose of a chemical molecule that is a precursor for the synthesis of a ... (Read 86 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
Injecting an animal with a dose of a chemical molecule that is a precursor for the synthesis of a synaptic neurotransmitter would be expected to
 
  A) reduce the availability of that neurotransmitter.
  B) increase the rate of synthesis and release of that neurotransmitter.
  C) alter the number of postsynaptic receptors.
  D) act as an antagonist at autoreceptors.
  E) increase neurotransmitter reuptake into the axon.

Question 2

Administration of a drug that binds at a postsynaptic site different from that of the neurotransmitter, and facilitates the opening of ion channels would be termed a(n)
 
  A) indirect antagonist.
  B) ligand.
  C) direct synergist.
  D) indirect agonist.
  E) indirect pheromone.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierrahalpin

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

Answer: B
Rationale: Injecting an animal with a dose of a chemical molecule that is a precursor for the synthesis of a synaptic neurotransmitter would be expected to increase the rate of synthesis and release of that neurotransmitter.

Answer to Question 2

Answer: D
Rationale: Administration of a drug that binds at a postsynaptic site different from that of the neurotransmitter, and facilitates the opening of ion channels would be termed an indirect agonist.




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library